BHCM
OLMA icon

Brevan Howard Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Brevan Howard Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Buy
+22,100
New +$296K ﹤0.01% 1754
2026
Q1 		– Sell
-107,950
Closed -$2.7M – 2386
2025
Q4 		$2.7M Buy
+107,950
New +$1.92M 0.03% 388
2024
Q3 		– Sell
-22,328
Closed -$242K – 1344
2024
Q2 		$242K Buy
+22,328
New +$242K ﹤0.01% 838

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Brevan Howard Capital Management's OLMA Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 22,100 shares worth $276K. The stake represents ﹤0.01% of the portfolio and ranks #1754 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in OLMA as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in OLMA in Q2 2024 and has held it in 3 quarters since. The position peaked at $2.7M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Brevan Howard Capital Management held 22,100 shares of Olema Pharmaceuticals worth $276K as of Q2 2026.
  • Olema Pharmaceuticals was a new Brevan Howard Capital Management position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1754 holding.
  • Brevan Howard Capital Management first reported a position in Olema Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's Olema Pharmaceuticals position peaked at $2.7M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.